Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Gastroenterology
Disease Category: Frequent Nighttime Urination (Nocturia)
Location: United States, CA

Clinical Trial Details

Overview

Research Study Summary

Frequent Nighttime Urination - Nocturia

Purpose

A Phase III Randomized, Double Blind, Placebo Control, Multicenter Study to Investigate the Efficacy and Safety of SER 120 Nasal Spray Formulation in Patients with Nocturia

Patient Inclusion Criteria:

  • Male or Female, 50 years of age or older
  • Nocturia 2 times nightly or greater for at least 6 months duration

Patient Exclusion Criteria:

  • Incontinence
  • Diabetes
  • CHF
  • Urinary Retention
  • Uncontrolled Hypertension
  • Urologic Malignancy
  • Interstitial Cystitis, Bladder stones, current UTI
  • Restless Leg Syndrome
  • Obstructive Sleep Apnea
  • Substance Abuse
  • Blood donation within 90 days
  • Smoking within one year

To Learn more
Phase

3

Gender

Both Male and Female

Age

50 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

West Coast Clinical Research
5525 Etiwanda Ave., Suite 202
Tarzana, CA 91356
Phone: 818-776-0820, Ext. 101
Fax: 818-776-1269

View Map

Research Center Information: West Coast Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 163171

Date Last Changed: July 24, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.